BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6316210)

  • 1. Dopamine- and cholecystokinin-containing neurons of the crossed mesostriatal projection.
    Fallon JH; Wang C; Kim Y; Canepa N; Loughlin S; Seroogy K
    Neurosci Lett; 1983 Oct; 40(3):233-8. PubMed ID: 6316210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The crossed mesostriatal projection: neurochemistry and developmental response to lesion.
    Altar A; Neve KA; Loughlin SE; Marshall JF; Fallon JH
    Brain Res; 1983 Nov; 279(1-2):1-8. PubMed ID: 6416611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent neuroplasticity in mesostriatal projections after unilateral removal of vibrissae in the adult rat: compartment-specific effects on horseradish peroxidase transport and cell size.
    Steiner H; Weiler HT; Morgan S; Huston JP
    Neuroscience; 1992; 47(4):793-806. PubMed ID: 1374540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collateralization of monoamine neurons: mesotelencephalic dopamine projections to caudate, septum, and frontal cortex.
    Fallon JH
    J Neurosci; 1981 Dec; 1(12):1361-8. PubMed ID: 6172572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal plasticity in the nigrostriatal system of the rat after unilateral removal of vibrissae.
    Huston JP; Morgan S; Lange KW; Steiner H
    Exp Neurol; 1986 Aug; 93(2):380-9. PubMed ID: 3015660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human substantia nigra and ventral tegmental area. A neuroanatomical study with notes on aging and aging diseases.
    van Domburg PH; ten Donkelaar HJ
    Adv Anat Embryol Cell Biol; 1991; 121():1-132. PubMed ID: 2053466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of non-dopamine neurons in substantia nigra and ventral tegmental area to amphetamine and apomorphine during hypermotility: the striatal influence.
    Olds ME
    Brain Res; 1988 Jun; 452(1-2):237-54. PubMed ID: 3401732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic and nicotinic cholinergic mechanisms in the mesostriatal dopamine systems.
    Zhou FM; Wilson C; Dani JA
    Neuroscientist; 2003 Feb; 9(1):23-36. PubMed ID: 12580337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynorphin-containing pathways in the substantia nigra and ventral tegmentum: a double labeling study using combined immunofluorescence and retrograde tracing.
    Fallon JH; Leslie FM; Cone RI
    Neuropeptides; 1985 Feb; 5(4-6):457-60. PubMed ID: 2860605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation by stress of the habenulo-interpeduncular substance P neurons in the rat.
    Lisoprawski A; Blanc G; Glowinski J
    Neurosci Lett; 1981 Aug; 25(1):47-51. PubMed ID: 6168982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible interaction between cholecystokinin and dopamine.
    Govoni S; Yang HY; Bosio A; Pasinetti G; Costa E
    Adv Biochem Psychopharmacol; 1982; 33():437-44. PubMed ID: 7124508
    [No Abstract]   [Full Text] [Related]  

  • 12. Mesostriatal projections from ventral tegmentum and dorsal raphe: cells project ipsilaterally or contralaterally but not bilaterally.
    Loughlin SE; Fallon JH
    Neurosci Lett; 1982 Sep; 32(1):11-6. PubMed ID: 6183620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular substrates for interactions between dynorphin terminals and dopamine dendrites in rat ventral tegmental area and substantia nigra.
    Pickel VM; Chan J; Sesack SR
    Brain Res; 1993 Feb; 602(2):275-89. PubMed ID: 8095430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catecholamine innervation of the basal forebrain. IV. Topography of the dopamine projection to the basal forebrain and neostriatum.
    Fallon JH; Moore RY
    J Comp Neurol; 1978 Aug; 180(3):545-80. PubMed ID: 659674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-dopaminergic nigrostriatal pathway.
    Guyenet PG; Crane JK
    Brain Res; 1981 Jun; 213(2):291-305. PubMed ID: 7248760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area.
    Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A
    Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of forebrain lesions in the neonatal rat: survival of midbrain dopaminergic neurons and the crossed nigrostriatal projection.
    Jaeger CB; Joh TH; Reis DJ
    J Comp Neurol; 1983 Jul; 218(1):74-90. PubMed ID: 6886067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions.
    Seroogy KB; Dangaran K; Lim S; Haycock JW; Fallon JH
    J Comp Neurol; 1989 Jan; 279(3):397-414. PubMed ID: 2563737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cholinergic projection to the rat substantia nigra from the pedunculopontine tegmental nucleus.
    Beninato M; Spencer RF
    Brain Res; 1987 May; 412(1):169-74. PubMed ID: 3038263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area.
    Sesack SR; Pickel VM
    J Comp Neurol; 1992 Jun; 320(2):145-60. PubMed ID: 1377716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.